Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics

Hyperkalaemia is a growing concern in the treatment of patients with heart failure and reduced ejection fraction (HFrEF) as it limits the use of some prognostic-modifying drugs and has a negative impact on prognosis. The objective of the present study was to estimate the prevalence of hyperkalaemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Delgado-Jiménez, Juan F., Segovia-Cubero, Javier, Almenar-Bonet, Luis, de Juan-Bagudá, Javier, Lara-Padrón, Antonio, García-Pinilla, José Manuel, Bonilla-Palomas, Juan Luis, López-Fernández, Silvia, Mirabet-Pérez, Sonia, Gómez-Otero, Inés, Castro-Fernández, Antonio, Díaz-Molina, Beatriz, Goirigolzarri-Artaza, Josebe, Rincón-Díaz, Luis Miguel, Pascual-Figal, Domingo Andrés, Anguita-Sánchez, Manuel, Muñiz, Javier, Crespo-Leiro, María G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910891/
https://www.ncbi.nlm.nih.gov/pubmed/35268260
http://dx.doi.org/10.3390/jcm11051170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910891/
https://www.ncbi.nlm.nih.gov/pubmed/35268260
http://dx.doi.org/10.3390/jcm11051170

Ejemplares similares